Fused pyridazine derivative compounds and drugs containing these compounds as the active ingredient

Fused pyridazine derivatives represented by formula (I) or pharmaceutically acceptable salts thereof (wherein each symbol has the meaning as defined in the specification.). Because of inhibiting poly(ADP-ribose)polymerase, the compounds represented by formula (I) are useful as preventives and/or rem...

Full description

Saved in:
Bibliographic Details
Main Authors TAKEUCHI JUN, TAKAHASHI SHINYA, KAMANAKA YOSHIHISA, SEKO TAKUYA, KAMOSHIMA WATARU
Format Patent
LanguageChinese
English
Published 15.10.2008
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Fused pyridazine derivatives represented by formula (I) or pharmaceutically acceptable salts thereof (wherein each symbol has the meaning as defined in the specification.). Because of inhibiting poly(ADP-ribose)polymerase, the compounds represented by formula (I) are useful as preventives and/or remedies for various ischemic diseases (in brain, cord, heart, digestive tract, skeletal muscle, retina, etc.), inflammatory diseases (inflammatory bowel disease, multiple cerebrosclerosis, arthritis, etc.), neurodegenerative diseases (extrapyramidal disorder, Alzheimer's disease, muscular dystrophy, lumbar spinal canal stenosis, etc.), diabetes, shock, head trauma, renal failure, hyperalgesia, etc. Moreover, these compounds are useful as agents against retroviruses (HIV etc.), sensitizers in treating cancer and immunosuppressants.
Bibliography:Application Number: CN20071153727